CorMedix Inc (NASDAQ:CRMD)’s traded shares stood at 0.68 million during the latest session, with the company’s beta value hitting 1.60. At the last check today, the stock’s price was $13.05, to imply an increase of 4.65% or $0.58 in intraday trading. The CRMD share’s 52-week high remains $12.67, putting it 2.91% up since that peak but still an impressive 80.31% since price per share fell to its 52-week low of $2.57. The company has a valuation of $753.77M, with an average of 1.1 million shares in intraday trading volume over the past 10 days and average of 929.69K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for CorMedix Inc (CRMD), translating to a mean rating of 1.00. Of 2 analyst(s) looking at the stock, 1 analyst(s) give CRMD a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.1.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CorMedix Inc (NASDAQ:CRMD) trade information
After registering a 4.65% upside in the latest session, CorMedix Inc (CRMD) has traded red over the past five days. The 5-day price performance for the stock is 18.53%, and 58.57% over 30 days. With these gigs, the year-to-date price performance is 247.07%. Short interest in CorMedix Inc (NASDAQ:CRMD) saw shorts transact 9.27 million shares and set a 9.45 days time to cover.
The extremes give us $9 and $9 for target low and target high price respectively. As such, CRMD has been trading 31.03% off suggested target high and 31.03% from its likely low.
CorMedix Inc (CRMD) estimates and forecasts
Revenue is forecast to grow 41.20% this quarter before jumping 96.20% for the next one.
Revenue forecast for the current quarter as set by 4 analysts is 10.84M. Meanwhile, for the current quarter, a total of 4 analyst(s) estimate revenue growth to 18.37M.
CRMD Dividends
CorMedix Inc has its next earnings report out on 2024-Oct-30. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
CorMedix Inc (NASDAQ:CRMD)’s Major holders
CorMedix Inc insiders hold 1.02% of total outstanding shares, with institutional holders owning 29.88% of the shares at 30.19% float percentage. In total, 29.88% institutions holds shares in the company, led by BLACKROCK INC. As of 2024-06-30, the company held over 3.55 million shares (or 6.1796% of shares), all amounting to roughly $15.39 million.
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 2.9 million shares, or about 5.0476% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $12.57 million.
